SCHEMBL7258507

SCHEMBL7258507

O=C(O)c1ccc(CNc2nc(NCc3cccs3)nc3ccc(Cl)cc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.55
HRH1 P35367 1/20 0.55
POLB P06746 1/20 0.49
CTNNB1 P35222 6/20 0.49
TCF7L2 Q9NQB0 6/20 0.49
CLK4 Q9HAZ1 3/20 0.48
CNR1 P21554 1/20 0.48
NPC1 O15118 1/20 0.47
HTR3A P46098 1/20 0.46
MEN1 O00255 2/20 0.45
USP2 O75604 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
TSHR P16473 2/20 0.45
CYP2C19 P33261 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255652 0.89 HRH4 (0.55) HRH4HRH1CTNNB1TCF7L2CLK4
SCHEMBL7259297 0.87 HRH1 (0.50) HRH4HRH1CTNNB1TCF7L2
SCHEMBL7258098 0.86 HRH1 (0.47) HRH4HRH1CTNNB1TCF7L2CLK4
SCHEMBL7260290 0.85 HRH4 (0.54) HRH4HRH1CLK4NPC1HTR3A
SCHEMBL7254578 0.85 HRH4 (0.60) HRH4HRH1CLK4NPC1HTR3A
SCHEMBL7254511 0.84 LMNA (0.56) CTNNB1TCF7L2CLK4MEN1USP2
SCHEMBL7254519 0.83 NPC1 (0.52) HRH4HRH1CTNNB1TCF7L2CLK4
SCHEMBL7071101 0.82 ADORA2A (0.53) CSNK2A1
SCHEMBL7259508 0.80 HRH4 (0.52) HRH4HRH1CLK4NPC1HTR3A
SCHEMBL7254764 0.80 CNR1 (0.57) HRH4CTNNB1TCF7L2CNR1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed